文献速递心脏核医学

中重度缺血患者中ISCHEMIA试验排除人群的结局分析

Outcomes of patients with moderate-to-severe Ischemia excluded from the ischemia trial.
PubMed 文献 · J Nucl Cardiol · 2021-07-06

本研究连续纳入1508例SPECT有灌注缺损的患者,其中47%存在中重度缺血,但66.3%至少符合一条ISCHEMIA试验排除标准。符合ISCHEMIA入组标准者全因死亡率显著低于被排除者(3.91% vs 11.3%,P<.001)。ISCHEMIA试验在常规中重度缺血人群中仅选择了较低危的少数亚组。

要点

  • SPECT中重度缺血患者中仅约三分之一符合ISCHEMIA入组标准。
  • 符合ISCHEMIA标准者全因死亡率显著低于被排除者(3.91% vs 11.3%)。
  • ISCHEMIA结论不宜直接外推至被排除的高危中重度缺血人群。

核心结论

  • ISCHEMIA试验在较大的中重度缺血高危人群中仅选择了相对小部分较低危患者。

研究设计与样本

  • 回顾性队列研究,连续纳入2016年4月至2019年9月接受心脏SPECT且存在灌注缺损的1508例患者,评估全因死亡率。

主要发现

  • 1508例患者平均年龄67±11.6岁,69.5%为男性,73.4%有高血压,54.4%有糖尿病。
  • 709例(47%)存在中重度缺血,其中479/709(66.3%)至少符合一条ISCHEMIA试验排除标准。
  • 符合ISCHEMIA入组标准者全因死亡率显著低于被排除者(3.91% vs 11.3%,P<.001)。

临床怎么用

  • 解读ISCHEMIA结果时需注意其入组人群为较低危亚组,不能直接推广至被排除的中重度缺血患者。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial showed no difference in outcomes between medical therapy vs coronary revascularization in the management of patients with stable coronary artery disease. We aimed to determine the percentage of patients with at least moderate ischemia that would have been eligible for enrollment and evaluate the outcomes of those who would not. METHODS: Consecutive patients who underwent cardiac single-photon emission computed tomography (SPECT) between April 2016 and September 2019 were identified and all-cause mortality was determined. RESULTS: There were a total of 1508 patients (mean age 67 ± 11.6 years, 69.5% males) with any perfusion defect on SPECT. Patients had a high prevalence of cardiac risk factors (73.4% with hypertension and 54.4% with diabetes mellitus.) Nearly half (709, 47%) had moderate-to-severe ischemia but over two-thirds (479/709, 66.3%) had at least one ISCHEMIA trial exclusion criteria. Patients meeting ISCHEMIA enrollment criteria had a significantly lower all-cause mortality than those who would have been excluded (3.91% vs. 11.3%, respectively, P < .001). CONCLUSION: Our results show that ISCHEMIA selected a relatively small subset of lower risk patients among the larger higher risk group of patients with moderate-to-severe ischemia typical to most cardiology centers.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Al-Mallah MH, Ahmed AI, Nabi F, et al. Outcomes of patients with moderate-to-severe Ischemia excluded from the ischemia trial. J Nucl Cardiol. 2021. PMID: 34324083. doi:10.1007/s12350-021-02679-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。